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The purinergic receptor system plays an important role in the
regulation of both vascular and tubular functions within the
kidney; however, the release of purinergic agonists other
than ATP by renal tissue is not known. In this investigation,
we determine if kidney tissue is a source of diadenosine
polyphosphates, which have high affinity for the P2X and P2Y
receptors. Both diadenosine pentaphosphate and
hexaphosphate were identified by matrix-assisted laser
desorption ionization–mass spectrometry in extracts purified
from both whole porcine kidney and from cloned cells of the
LLC-PK1 cell line. Both polyphosphates in nanomolar
concentrations were found to significantly stimulate the
proliferation of vascular smooth muscle cells derived from rat
thoracic aortas. The purinergic-receptor antagonist, suramin,
did not significantly affect the growth-stimulatory properties
of the polyphosphates. The growth stimulation of vascular
smooth muscle cells by platelet-derived growth factor was
potentiated by both diadenosine polyphosphates. We
conclude that diadenosine polyphosphates are endogenous
purinergic agonists of the kidney that have physiologic and
pathophysiologic relevance. These epithelial cell metabolic
products have vasoregulatory properties while linking the
energy supply and tubular function.
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published online 14 March 2007
KEYWORDS: diadenosine; polyphosphates; proliferation; tubular cell
Purinergic signalling importantly contributes to the control
of renal vascular and tubular function. Afferent arteriolar
tone is under control of P2X1 receptors, effecting fine-tuning
of glomerular perfusion and filtration.1 Numerous tubular
functions are regulated via purinergic mechanisms. Luminal
P2Y receptors are expressed along the whole distal nephron
down to inner medullary collecting duct.2 P2Y2 receptors are
the predominant subtype in the distal nephron, but P2Y1,
P2Y4, and P2Y6 subtypes have also been found.
3 Multiple
tubular functions are mediated by P2Y receptors. Luminal
nucleotides increase cytosolic-free Ca2þ concentration and,
thereby, inhibit Naþ and Ca2þ reabsorption and stimulate
Cl secretion.4,5 Purinergic inhibition of distal Naþ reabsorp-
tion is mediated by inhibition of basolateral Na–K–Cl
cotransport and of amiloride-sensitive Naþ reabsorption.4,6
Moreover, purinergic regulation of Kþ secretion via renal
outer medullary potassium channels (ROMK channels) and
on aquaporin-2-mediated water transport has been de-
scribed.7,8 Proximal tubular P2 receptor expression is less
clear.2
Given that purinergic signalling plays an important role in
the regulation of tubular function, the question arises as to
the source of nucleotide messengers active in renal tissue.
Luminal secretion of ATP by epithelial cells has been
demonstrated,9 but nothing is known regarding the secretion
of other nucleotides. We examined, therefore, whether renal
tissue is the source of a specific group of endogenous
purinergic agonists, the diadenosine polyphosphates. These
endogenous nucleotides have recently attracted growing
interest as they show high affinities to specific P2X and P2Y
receptor subtypes.10 Lacking free phosphate groups, dia-
denosine polyphosphates are much more resistant to extra-
cellular degradation than mononucleoside polyphosphates.11
This study reveals that diadenosine pentaphosphate
(Ap5A) and diadenosine hexaphosphate (Ap6A) are compo-
nents of renal tissue and renal proximal tubule cells obviously
secrete these mediators on stimulation. These findings
suggest that autocrine purinergic control of vascular and
tubular functions by complex nucleotides may be of
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physiological and pathophysiological relevance, providing a
link between tubular function and energy supply as well as
other functions of the vascular system like infiltration of
blood cells to the interstitial space.
RESULTS
The anion-exchange chromatogram obtained from a selected
fraction of the displacement-chromatography is given in
Figure 1a. The eluate of the anion-exchange chromato-
graphy was fractionated by reversed-phase chromatography.
Figure 1b shows a reversed-phase chromatography from the
peak labelled in Figure 1a. As in the preceding chromato-
graphic step, this fraction was chosen on the basis of the
retention time typical for diadenosine polyphosphates in this
chromatographic setting. The fraction labelled by an arrow in
Figure 1b was rechromatographed by reversed-phase chro-
matography using the same conditions as before. In the last
chromatographic step, a single UV peak was obtained (data
not shown). The molecular structure of the underlying
substance was determined by matrix-assisted laser desorption
ionization–mass spectrometry using the methods and
condition described previously.12,13 Hereby, the underlying
substance was identified as Ap5A and Ap6A. After identifica-
tion of Ap5A and Ap6A from porcine kidneys, Ap5A
and Ap6A were isolated and identified from human kidney
tissue too.
After we had identified Ap5A and Ap6A in extracts from
renal tissue, the question arose as to which renal cells are the
source of diadenosine polyphosphates. As epithelial cells have
been shown to secrete Ap5A and Ap6A, we examined whether
cultured renal proximal tubule cells secrete diadenosine
polyphosphates on stimulation. Figure 2 shows the resulting
concentrations of Ap5A (Figure 2a) and Ap6A (Figure 2b) in
the supernatant of LLC-PK1 cell line during stimulation with
OAG. Ap5A and Ap6A concentrations in the supernatant of
unstimulated LLC-PK1 cells are considerably lower than with
stimulated cells. After stimulation with 500 mmol/l OAG, the
Ap5A and Ap6A release increased time dependently. Figure 2c
and d demonstrate the dose-dependent effect of OAG on the
release of Ap5A and Ap6A in detail. The experiments revealed
significant differences (Po0.05) in stimulated versus un-
stimulated LLC-PK1 cells with OAG concentration above
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Figure 1 | Isolation of diadenosine pentaphosphate and dia-
denosine hexaphosphate from kidney tissue. (a) Chromatogram
of anion-exchange chromatography of one fraction of the
displacement chromatography (abscissa: retention time (min);
ordinate: UV-absorption (arbitrary units)). (b) Chromatogram
of reversed-phase chromatography of the fraction labelled in
b (abscissa: retention time (min); ordinate: UV-absorption
(arbitrary units)).
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Figure 2 | Release of diadenosine pentaphosphate and diadenosine hexaphosphate from tubular cells. Increased Ap5A and Ap6A
concentrations in supernatants of (a, and b) stimulated rat proximal tubular LLC-PK1 (a, Ap5A; b, Ap6A); (c and d) rat proximal tubular LLC-PK1
cells after stimulation with increasing OAG concentrations (c, Ap5A; d, Ap6A); (e) stimulated human proximal tubular cells HK-2 cells (e, Ap5A:
left y-axis; Ap6A: right y-axis); (f) stimulated rat isolated rat proximal tubules (f, Ap5A: left y-axis; Ap6A: right y-axis); data are means7s.e.m.;
n¼ 3; *Po0.05 compared with control; open bars, before stimulation; filled bars, after stimulation).
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100 nmol/l. Not only proximal tubular cells of rats, but also
proximal tubular cells of humans release Ap5A (Figure 2e; left
y-axis) and Ap6A (Figure 2e; right y-axis) after OAG
stimulation.
However, release of Ap5A and Ap6A is not only an effect of
the immortalized cell lines like LLC-PK-1 and HK-2 cells, but
also an effect of native cells. The amount of Ap5A and Ap6A
released by freshly isolated proximal tubules are comparable
to release by cell lines (Ap5A: Figure 2f; left y-axis; Ap6A:
Figure 2f; right y-axis).
The incubation of VSMCs with Ap5A and Ap6A induced a
concentration-dependent increase in proliferation as deter-
mined by [3H]-thymidine uptake (Figure 3a). Ap5A and
Ap6A were effective in the nanomolar range. The maximum
stimulation of DNA synthesis promoted by Ap5A and
Ap6A was observed at a concentration of 10 mmol/l. At this
concentration, Ap5A and Ap6A induced an increase in
VSMCs [3H]-thymidine uptake of 301742% and 8177
105% above control, respectively. For comparison, Figure 3a
demonstrates the effects of ATP, uridine triphosphate, and
a,b-methylene ATP on 3H-thymidine incorporation. These
substances were much less effective in stimulating [3H]-
thymidine uptake than Ap5A and Ap6A (Figure 3a). The
effect of Ap5A and Ap6A on VSMC proliferation was
confirmed by cell counting (Table 1).
The growth-stimulating effect of Ap5A and Ap6A was not
significantly inhibited by both the purinergic-receptor
antagonist, suramin ([3H]-thymidine uptake of 118.077.0
versus 105.078.0% above control) and pyridoxalphosphate-
6-azophenyl-2,4-disulphonic acid (93.974.5 versus 96.376.8
% above control) indicating that suramin- and pyridox-
alphosphate-6-azophenyl-2,4-disulphonic acid-insensitive re-
ceptors may be involved in the growth-promoting effect.
After Ap5A and Ap6A had been shown to stimulate growth
of VSMCs, the interaction of these substances with PDGF
was also examined. As shown in Figure 3b, the effect of PDGF
on VSMC growth was markedly enhanced (Po0.001).
Figure 3c depicts the effects of Ap5A and Ap6A alone as
well as together with PDGF on RNA synthesis as measured by
[3H]-uridine incorporation rate. Both diadenosine polypho-
sphates increased RNA synthesis and markedly enhanced the
RNA synthesis induced by PDGF. Furthermore, the effect of
Ap5A or Ap6A on RNA synthesis reached its maximum much
earlier than that of PDGF. The effects of Ap5A and Ap6A on
protein synthesis as measured by [3H]-leucine incorporation
rate are shown in Figure 3d. Compared with PDGF, both
Ap5A and Ap6A stimulated protein synthesis only moderately
and did not further enhance the PDGF-induced protein
synthesis.
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Figure 3 | Effect of diadenosine pentaphosphate and diadenosine hexaphosphate on the proliferation rate of vascular smooth muscle
cells. (a) Incorporation of [3H]-thymidine in VSMC induced by Ap5A (’), Ap6A (K), ATP (J), uridine triphosphate (,), a, b-methylene ATP (&)
(abscissa: log of concentration (mol/l); data are means7s.e.m.; n¼ 5 with 10 cultures each; *Po0.05; **Po0.01 compared with control).
(b) Incorporation of [3H]-thymidine in VSMCs induced by 5 ng/ml PDGF without (J) and with Ap5A (’) or Ap6A (K) (abscissa: PDGF
concentration; data are means7s.e.m.; n¼ 4 with 10 cultures each. ***Po0.001 compared with PDGF alone). (c) Time course of incorporation
of [3H]-uridine in VSMCs induced by 10 mmol/l Ap5A (&) and Ap6A (W), 5 ng/ml PDGF (K) and by PDGF together with either Ap5A (’) or Ap6A
(m) (abscissa: time (h); data are means7s.e.m.; n¼ 6 with 10 cultures each. ***Po0.001 compared with PDGF alone). (d) Time course of
incorporation of [3H]-leucine in VSMCs induced by 10 mmol/l Ap5A (&) and Ap6A (n), 5 ng/ml PDGF (K) and by PDGF together with either
Ap5A (’) or Ap6A (m) (abscissa: time (h); data are means7s.e.m.; n¼ 6 with 10 cultures each. ***Po0.001 compared with PDGF alone).
Table 1 | Effects of Ap5A and Ap6A on proliferation of VSMCs
as measured by cell counting
Concentration (mol/l) Ap5A Ap6A
0 (Control) 7.570.8 7.570.8
107 7.770.6 7.870.4
106 8.270.9* 8.570.7*
105 12.171.1* 12.371.2*
104 12.071.0* 12.270.9*
0 with 10% FCS 19.172.1* 19.172.1*
VSMC, vascular smooth muscle cell.
Data are mean7s.e.m.
*Po0.05 versus control.
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DISCUSSION
The results of this study document that renal tissue contains
significant amounts of diadenosine polyphosphates and that
tubular cells are one of the sources of these diadenosine
polyphosphates.
It is already well-known that diadenosine polyphosphates
are released into the circulation from activated platelets14–16
from chromaffin cells of the adrenal glands,17–19 heart
tissue,20 and from synaptic vesicles21 and that they act as
strong vasoconstrictive substances, mostly mediated by P2X
receptors (e.g., van der Giet et al.22,23), and have strong
regulatory properties on the growth of mesangial cells.24
Kidney tissue is obviously a further important source
releasing diadenosine polyphosphates after stimulation.
These diadenosine polyphosphates have not only strong
vasoconstrictive properties but also act as strong growth-
stimulating mediators of VSMCs. These results confirm
previous data suggesting stimulation of vascular growth
by diadenosine polyphosphates.25 Ap5A and Ap6A markedly
enhanced the DNA and RNA synthesis, but not the protein
synthesis induced by PDGF. These findings suggest that
Ap5A and Ap6A function by a different pathway than
PDGF, which may act as a regulatory factor, that is, in the
initial phase of the mitogenic cycle preceding the DNA
synthesis.
Is there a role for tubular diadenosine polyphosphates
acting on renal vasculature? Given the close vicinity of
tubules and peritubular vessels, a paracrine function for
diadenosine polyphosphates secreted by renal tubules is not
unlikely. Moreover, the high-energy consumption by renal
tubular cells necessitates a feedback regulation of vascular
supply by renal tubules. Diadenosine polyphosphates-
induced VSMC proliferation may be one element playing a
role in tubular vasoregulation, providing a link between
tubular function and energy supply as well as other cell
functions like the infiltration of blood cells to the interstitial
space, especially in pathophysiological conditions.
What is the relevance of these findings for renal
pathophysiology? The understanding of purinergic mechan-
isms in the regulation of tubular and renal vascular functions
is at its very beginning. At present, studies mainly focus on
the role of ATP as a purinergic agonist. As it has been well
documented that diadenosine polyphosphates show a profile
of action different from that of ATP and other mononucleo-
tides,10,26,27 diadenosine polyphosphates may play a specific
role in the purinergic regulation of renal functions. The renal
actions of diadenosine polyphosphates may be mediated by
purine receptors both in the renal epithelia and renal
vasculature.
Which purinergic receptors may be involved in this
process? Renal diadenosine polyphosphates may mediate
important actions via P2X receptors located on renal
microvessels. It has been already demonstrated that the
autoregulatory constriction of afferent glomerular arterioles
is largely mediated by P2X1 receptors
1 and that diadenosine
polyphosphates are strong agonists of P2X1 receptors.
27,28
Hence, diadenosine polyphosphates may play a significant
role in pressure-induced afferent arteriolar autoregulatory
responses. Given that diadenosine polyphosphates act on
P2X1 receptors with a much higher affinity and a much longer
half-life than ATP, diadenosine polyphosphates may impor-
tantly contribute to renal vasoregulation.
Moreover, in renal epithelial cells, multiple P2Y receptor
subtypes are expressed, which vary along the different
segments of the nephron. The precise role of each
P2Y-receptor subtype has not yet been elucidated. P2Y1, P2Y2,
and P2Y6 receptors have been demonstrated in renal
epithelia;3,29 however, these receptors are thought to be
implicated in regulating salt and water balance. P2Y
stimulation results in increased salt and water excretion,
suggesting a role of these receptors in hypertension and
in disorders of volume regulation.7 Diadenosine polypho-
sphates decrease energy-consuming processes like tubular
Naþ reabsorption and effectively stimulate diuresis.30 It is
very likely that the stimulatory effect of diadenosine
polyphosphates on VSMC growth is mediated by P2Y
receptors.31
The metabolism of the diadenosine polyphosphates has
not been clarified yet, but it has been suggested that these
agents are cleaved by phosphodiesterases,32 meaning that the
diadenosine polyphosphates may be cleaved asymmetrically.
This indicates that the effects of Ap5A and Ap6A could be
produced by ATP generated from the diadenosine polyphos-
phates. However, this possibility seems unlikely, as both
diadenosine polyphosphates are effective in much lower
concentrations than ATP.
In conclusion, diadenosine polyphosphates stimulate cell
proliferation and, hence, regenerative processes. Therefore,
the physiological effects of diadenosine polyphosphates may
be explained by the combined effects of P2 receptor
stimulation in the renal epithelia and renal vasculature.
Thus, diadenosine polyphosphates secreted by renal tubular
epithelia may function as autocrine and paracrine messengers
mediating important regulative processes in renal physiology
and pathology.
Furthermore, our experiments show that renal tissue
contains significant amounts of Ap5A and Ap6A. These
nucleotide messengers probably mediate purinergic effects on
renal vascular function. In addition to the well-known P2X
receptor-mediated actions on vasculature and tubules, Ap5A
and Ap6A are potent stimulators of VSMC growth and, thus,
may contribute to remodelling processes in renal tissue. It
remains to be clarified whether this process can be
characterized as a protective or noxious effect.
MATERIALS AND METHODS
Materials
High-pressure liquid chromatography water (gradient grade) and
acetonitrile were from Merck (Darmstadt, Germany). All other
substances were purchased from Sigma (Taufkirchen, Germany),
unless otherwise indicated.
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Purification procedures of AP5A and AP6A from renal tissue
Firstly, porcine kidneys were purchased from a local slaughterhouse.
Kidney tissue was immediately placed in ice-cold physiological
saline and cut into small pieces. Tissue was frozen, lyophilized,
and powdered. Twenty grams of tissue (dry weight) was homo-
genated with perchloric acid. Treatment of the cells with
perchloric acid prevented enzymatic degradation of diadenosine
polyphosphates and removed most proteins. The extract was
centrifuged at 100 000 g and the supernatant was neutralized with
KOH to pH 9.5.
The chromatographic procedure for the isolation of diadenosine
polyphosphates is comparable to previously described methods (see
Jankowski et al.12,13).
The purification strategy detailed in the following is a
modification of procedures, which were developed for the isolation
of diadenosine polyphosphates in earlier studies.12,13 Briefly, the
extract from renal tissue was fractionated by size-exclusion
chromatography. Afterwards, the mononucleoside polyphosphates
and dinucleoside polyphosphates of the low-molecular weight-
containing fractions of the size-exclusion chromatography were
separated by affinity chromatography. Next, the desalted and
lyophilized eluate of the affinity chromatography was fractionated
by reversed-phase displacement chromatography. The fractions
resulting from the displacement chromatography were fractionated
by anion-exchange chromatography.
After centrifugation, strong hydrophilic substances as well as
strong hydrophobic substances were separated from the dinucleo-
side polyphosphates by reversed-phase chromatography. For this,
triethylammonium acetate was added to the extract of kidney tissue.
The supernatant was pumped through a preparative reversed-phase
column (Lichroprep, 310 65 mm, 40–65 mm; Merck, Germany).
After removing substances not binding to the column with aqueous
40 mmol/l triethylammonium acetate, the absorbed molecules were
eluted with 20% acetonitrile in water. The elution was detected by
measuring the UV absorption at 254 nm.
The eluate was lyophilized and fractionated by size-exclusion
chromatography using water as eluent. This eluent repulsion and the
adsorption effects of the size-exclusion gel reinforce each other
leading to repulsion of the anionic diadenosine polyphosphates by
the carboxyl group of the gel. As a result, diadenosine polypho-
sphates elute earlier than one would expect, based on their
molecular weight. The lyophilized samples from the reversed-phase
column were dissolved in 5 ml water and were loaded to a size-
exclusion gel (Sephacryl S-100; Pharmacia, Uppsala, Sweden). The
effluate was monitored with a UV detector at 254 nm.
Next, the fraction eluted from the size-exclusion gel was passed
through a phenylboronic acid affinity column. The affinity
chromatography gel specifically binds dinucleoside polyphosphates
discriminating against mononucleoside polyphosphates. Binding
substances were eluted with 10 mmol/l HCl. The desalted eluate of
the affinity chromatography was injected on a C18 reversed-phase
column (Supersphere C18 endcapped, 100 2.1 mm, 4mm; Merck,
Germany). The carrier was pumped through the system at a
flow rate of 10 ml/min. After the injection was completed,
n-butanol (160 mmol/l) was used as displacer. The fraction size
was 100ml. For further purification, fractions of the displacement
chromatography were selected according to the retention time
shown to be typical for diadenosine polyphosphates in earlier
studies using the same chromatographic procedure.12,14 Afterwards,
the fractions from the displacement chromatography were fractio-
nated by anion-exchange chromatography. The anion-exchange
column (Mono-Q PC3.2/2. 32 2 mm; Pharmacia, Sweden) was
equilibrated with eluent A (20 mmol/l K2HPO4, pH 8.0). The
sample dissolved in eluent A was injected to the column. Binding
substances were eluted using a linear gradient with increasing
concentration of eluent B (20 mmol/l K2HPO4 with 1 mol/l NaCl,
pH 8.0).
The fractions from anion-exchange chromatography were
further separated by reversed-phase high-pressure liquid chromato-
graphy (Supersphere 100 RP C18 endcapped, 250 4 mm; Merck,
Germany). The fractions dissolved in eluent A (40 mmol/l
triethylammonium acetate in water) were injected to the high-
pressure liquid chromatography. The pH of the samples was titrated
to 6.5 with HCl. Binding substances were eluted by a linear gradient.
Fractions with a significant UV absorption at 254 nm were
rechromatographed using the condition as described.
The lyophilized fractions from the reversed-phase chromato-
graphy were examined by matrix-assisted laser desorption ioniza-
tion–mass spectrometry and by enzymatic cleavage experiments as
described.13,33
Afterwards, human renal tissue was extracted as described above.
The extract was fractionated by preparative and analytic reversed-
phase and affinity chromatography as described above.
VSMC culture and proliferation assays
Vascular smooth muscle cells (VSMCs) were obtained from thoracic
aortas of normotensive Wistar–Kyoto rats and cultured by the tissue-
explant method.34,35 Briefly, cells were incubated in Dulbecco’s
modified Eagle’s medium (Gibco, Karlsruhe, Germany). Cultures
were incubated at 371C. When VSMCs had formed a confluent
monolayer, they were harvested by adding 0.05% trypsin and the
culture was continued up to eight passages.36 To ascertain that
cultured cells were VSMCs, immunocytochemical localization of a-
actin was carried out.36 Immunocytochemical staining of cells with
antibodies against von-Willebrand factor confirmed that cultured
VSMCs were free from contamination.
VSMCs were subcultured at a density of 5 104 cells/ml and kept
in culture medium containing 10% fetal calf serum to reach a
subconfluent monolayer. Cell growth was arrested by transferring
them into 0.5% fetal calf serum. Quiescent VSMCs were then
exposed to fresh culture medium with and without Ap5A, Ap6A,
ATP, uridine triphosphate, and a, b-methylene ATP (each
109–105 mol/l), respectively. After incubation, VSMCs were
pulsed with 2 mCi/ml [3H]-thymidine, trypsinized, and harvested
onto filter paper. Incorporated counts were measured by a
scintillation counter.
In separate experiments, VSMCs were incubated with diadeno-
sine polyphosphates in the presence or absence of suramin
(100 mmol/l)37,38 and pyridoxalphosphate-6-azophenyl-2,4-disul-
phonic acid (10 mmol/l), respectively.
Furthermore, VSMCs were incubated in the presence of
5 ng/ml platelet-derived growth factor (PDGF) in presence or
absence of 10 mmol/l Ap5A and Ap6A, respectively. Additional
experiments for estimation of cell growth were performed
by counting VSMC numbers microscopically and by measuring
[3H]-thymidine-incorporation into acid-precipitable material. All
experiments gave results comparable to the aforementioned method.
Moreover, the VSMCs were pulsed with 2 mCi/ml [3H]-uridine for
determination of RNA synthesis or 2 mCi/ml [3H]-leucine for
quantitation of protein synthesis.39 The cells were analyzed as
described above.
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Culture and stimulation of renal tubular cells
To test the hypothesis that renal tubular epithelial cells secrete Ap5A
and Ap6A on stimulation, experiments with immortalized porcine
(LLC-PK10 cells) and human proximal (HK 2 cells) tubular cells
were performed.
LLC-PK10 cells (a gift from Dr BA Molitoris, Indiana University
School of Medicine, Indianapolis, INUSA) from passage 70 to 90, a
clone of porcine proximal tubule LLC-PK1 cells, were utilized for all
studies. LLC-PK10 cells were maintained in 1:1 Dulbecco’s modified
Eagle’s medium/Ham’s F-12 medium (GIBCO, Germany) supple-
mented with 10% fetal calf serum, 100 IU/ml penicillin, 100mg/ml
streptomycin, 14 mmol/l NaHCO3, and 12.5 mmol/l 4-(2-hydro-
xyethyl)-1-piperazineethanesulfonic acid. HK-2 cells (immortalized
human proximal tubular cells; American Type Culture Collection,
LGC Promochem, Wesel, Germany) were maintained in keratocyte
serum-free-medium (GIBCO BRL, Germany) supplemented with
5 ng/ml epidermal growth factor, 40 ng/ml bovine pituitary extract,
100 IU/ml penicillin, and 100 mg/ml streptomycin. Both cells lines
were maintained in a 5% CO2 incubator at 371C. For all
experiments, LLC-PK10 cells were grown to confluency and HK-2
cells to approximately 80% confluency. In both cell lines, before
stimulation with 1-oleoyl-2-acetylglycerol (OAG), medium was
discarded and the cells cautiously rinsed three times with warm
phosphate-buffered saline (PBS). Thereafter, LLC-PK10 cells were
stimulated at 201C on a rocker (i) with 500 nmol OAG dissolved in
PBS for 1, 5, 10, or 20 min or (ii) with 100, 500, and 1000 nmol OAG
dissolved in PBS for 10 min.
HK-2 cells were stimulated at 201C on a rocker with 500 nmol
OAG dissolved in PBS for 10 min. Collection and processing of the
supernatants of five cell flasks for each experiment as well as control
experiments were performed as described for isolated proximal
tubules.
After incubation, aliquots of the supernatant were immediately
stored on ice and perchloric acid added for protein precipitation.
The samples were gently stirred and centrifuged. The supernatant of
five cell flasks was collected, adjusted to pH 10, and samples were
frozen. For control experiments, five cell flasks with LLC-PK10 cells
were treated similarly, but OAG was omitted, and cells were only
incubated with PBS.
Afterwards, the supernatants were chromatographed for isolation
of Ap5A and Ap6A. First, the supernatants of proximal tubule cells
were concentrated by preparative reversed-phase chromatography
using two analytic reversed-phase columns (Chromolith,
100 4.6 mm; Merck, Germany). As an internal standard, 10 mg
ApcpcpA was used. The retained substances were fractionated by
water with 40 mmol/l triethylammonium acetate as ion-pair reagent
as eluent A and 80% acetonitrile in water as eluent B by a step-wise
gradient. The eluate of the analytical reversed-phase chromatogra-
phy was fractionated by affinity chromatography as described above.
The eluate of the affinity chromatography gel was fractionated by
two reversed-phase high-pressure liquid chromatography columns
(Chromolith, 100 4.6 mm; Merck, Germany) using the chromato-
graphic methods as described above. The amount of Ap5A and Ap6A
was quantified by matrix-assisted laser desorption ionization–mass
spectrometry.40
Isolated proximal tubules
Next, the Ap5A and Ap6A secretation of isolated rat proximal
tubules were analyzed. Rat proximal tubules were freshly isolated as
recently described.41 Male Sprague–Dawley rats (220–300 g of body
weight) were anesthetized with ketaminhydrochloride (100 mg/kg
body weight, intraperitoneally) and xylazinhydrochloride (5 mg/kg
body weight, intraperitoneally) and abdominal incision was
performed. The renal arteries were cannulated and flushed with
40 ml of ice-cold (41C), oxygenated, and heparinized (1% of a
5000 I.E./ml heparin solution) buffer solution A containing (in
mmol/l): 112 NaCl, 20 NaHCO3, 5 KCl, 1.6 CaCl2, 2 NaH2PO4, 1.2
MgSO4, 5 glucose, 10 4-(2-hydroxyethyl)-1-piperazineethanesulfo-
nic acid, 10 mannitol, 1 glutamine, 1 sodium butyrate, 1 sodium
lactate, adjusted to pH 7.3 at 371C. Perfusion was continued with
30 ml of ice-cold solution A containing 5 mg of collagenase and
12.5 mg of hyaluronidase (Boehringer Biochemical, Mannheim,
Germany). After perfusion, the kidneys were removed and
transferred into ice-cold solution A. Renal cortices were dissected
and minced on an ice-cold Petri dish. Tissue fragments were washed
twice with 50 ml of oxygenated solution A followed by incubation
for 30 min with 30 ml of oxygenated solution A containing 10 mg
collagenase and 7.5 mg of hyaluronidase in a shaking water bath at
371C. Digestion was stopped by incubation in 15 ml of ice-cold
solution A containing 0.5 g of fatty acid free bovine serum albumin
(Serva, Heidelberg, Germany). After filtering the tissue through a tea
strainer and washing to remove the albumin, proximal tubules were
separated by percoll gradient centrifugation (10 min at 11 000 g),
using 45% percoll (Pharmacia, Sweden). Proximal tubules were
recovered from the lowest band, which was primarily composed of
proximal tubules (495%) without containing glomeruli. Tubules
were suspended in oxygenated solution B, containing (in mmol/l):
106 NaCl, 20 NaHCO3, 5 KCl, 1 CaCl2, 2 NaH2PO4, 1 MgSO4, 5
glucose, 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 2
glutamine, 10 sodium butyrate, 4 sodium lactate, adjusted to pH
7.05 at 41C in a siliconized Erlenmeyer flask (200 ml). The tubule
suspension containing 0.5–1.0 mg/ml of protein determined by the
Lowry method was gassed on ice for 5 min with 95% O2/5% CO2.
Tubules were placed in a shaking water bath at 371C for 10 min.
Aliquots were washed three times in PBS and centrifuged (1 min at
700 g). Thereafter, proximal tubules were incubated with 500 nmol
OAG dissolved in PBS at 201C on a rocker for 10 min. The
supernatant was collected, immediately stored on ice and 0.6 mol/l
perchloric acid added for protein precipitation. The samples were
gently stirred for 1 min and centrifuged at 2100 g for 10 min at 41C.
The supernatant was collected, immediately adjusted to pH 10 with
10 mol/l KOH, and samples were frozen at 201C until measure-
ment of diadenosine polyphosphates. For control experiments,
proximal tubules were treated similarly, but OAG was omitted and
proximal tubules were only incubated with PBS.
Statistical analysis
Data are presented as mean7s.e.m. Results were tested for
statistical significance using the Mann–Whitney U-test.
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